No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Press Release: GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
GeneDx Expands Commercial Footprint for Exome and Genome Testing With Inborn Errors of Immunity as a New Indication
GeneDx Holdings' Insiders' Timely Sale May Have Helped Mitigate 12% Dip in Share Price
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now?
Express News | GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)